Sputnik creators claim “strong defense” against Omigron

The authors of the Russian vaccine Sputnik V on Thursday joined President Vladimir Putin in a similar statement, calling it a “strong defense” against the Omigron variant of the Kovit-19.

The Russian Sovereign Fund claims that its vaccine has more than twice as much neutralizing effect on viral activity than its competitor Pfizer.

In addition, they cited a study by the Italian laboratory Spallanzani in collaboration with researchers at the Kamaleya Center, the inventor of Sputnik V.

Sputnik is not WHO approved

The Russian vaccine has not yet been discovered Approved A process that has been stalled for months by disagreements with Moscow over information to be provided by the World Health Organization (WHO).

Putin recently said that the Russian vaccine against the highly contagious Omigran variant was “more effective than any other used in the world.”

In Latin America, by the end of 2020, Argentina was the first country to homologate the vaccine Sputnik V, already approved by 69 countries.

It has been used in Mexico, Guatemala, Venezuela and Bolivia, as well as other states in the region.

Govt case record

Creator Reports Sputnik This is at a time when the city of Moscow has registered new cases of the new corona virus this Thursday with 11,557 infections in the last 24 hours.

Russia, the European country with the highest number of deaths from Kovit-19, has recorded 324,060 deaths from the disease since the outbreak, according to official figures.

But the National Statistics Agency’s Rosstat report put the death toll at more than 600,000 at the end of November.

Despite Sputnik V’s possession, the Russian government is having trouble convincing citizens to get vaccinated.

Less than half of the population is fully vaccinated today.